US equities |
MU $1,035.84 ▼-4.79% NVDA $230.48 ▼-2.94% SNDK $1,609.46 ▼-4.90% AMD $620.68 ▼-3.90% INTC $107.08 ▼-5.34% AAPL $340.42 ▲+1.11% META $720.89 ▼-0.06% SPCX $160.57 ▼-4.19%
FinancialContent

AngioDynamics, Inc. - Common Stock (NQ:ANGO)

11.23 -2.96 (-20.86%)
Delayed Quote Updated: 4:00 PM EDT, Oct 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AngioDynamics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
Crude Oil Down 1%; US Weekly Jobless Claims Decline ↗
 
Via Benzinga
News headline image
AAR Posts Upbeat Results, Joins AngioDynamics, eBay, Cal-Maine Foods And Other Big Stocks Moving Higher On Wednesday ↗
 
Via Benzinga
News headline image
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
From AngioDynamics, Inc.
Via Business Wire
News headline image
Earnings Scheduled For January 8, 2025 ↗
 
Via Benzinga
News headline image
In-Depth Examination Of 4 Analyst Recommendations For AngioDynamics ↗
 
Via Benzinga
News headline image
4 Analysts Assess AngioDynamics: What You Need To Know ↗
 
Via Benzinga
News headline image
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System
From AngioDynamics, Inc.
Via Business Wire
News headline image
Limoneira And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Receives FDA Clearance for The NanoKnife® System for Prostate Tissue Ablation
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics and University College London Hospital Launch International Multi-Center Study to Assess Long Term Effects of Treatment with The NanoKnife® System
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Announces American Medical Association’s CPT® Editorial Panel Grants Category I CPT® for Irreversible Electroporation (IRE) in Prostate and Liver
From AngioDynamics, Inc.
Via Business Wire
News headline image
3 Stocks Insiders Are Buying Heavily In October 2024, And Why ↗
Should investors add these stocks on their watchlist? Insider buys suggest so. 
Via Talk Markets
News headline image
Nasdaq Moves Lower; Levi Strauss Shares Slide ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Jumps Over 4%; US Services PMI Revised Lower ↗
 
Via Benzinga
News headline image
Why AngioDynamics Stock Is Crashing Today ↗
Investors didn't like the medical technology company's fiscal 2025 Q1 update. 
Via The Motley Fool
News headline image
AngioDynamics, Ingevity, Levi Strauss And Other Big Stocks Moving Lower On Thursday ↗
 
Via Benzinga
News headline image
US Stocks Staring At Another Weak Open As Traders Await Key Jobs Report; Sentiment Wavers As Oil Extends Surge Amid Middle East Tensions ↗
Sentiment continues to be cautious as traders play the “wait-and-watch” game until they see off Friday’s non-farm payroll data. The index futures traded moderately lower early Thursday. 
Via Benzinga
News headline image
AngioDynamics Reports Fiscal Year 2025 First Quarter Financial Results
From AngioDynamics, Inc.
Via Business Wire
News headline image
Top Wall Street Forecasters Revamp AngioDynamics Price Expectations Ahead Of Q1 Earnings ↗
 
Via Benzinga
News headline image
S&P Settles Slightly Higher Despite Middle East Concerns: Fear Index Remains In 'Greed' Zone ↗
 
Via Benzinga
Topics Stocks
News headline image
Constellation Brands, Levi Strauss And 3 Stocks To Watch Heading Into Thursday ↗
 
Via Benzinga
News headline image
AngioDynamics Initiates RECOVER-AV Clinical Trial Assessing AlphaVac F18⁸⁵ System in Treatment of Pulmonary Embolism and Long-Term Functional Outcomes
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics to Report Fiscal 2025 First Quarter Financial Results on October 3, 2024
From AngioDynamics, Inc.
Via Business Wire
News headline image
AngioDynamics Announces CE Mark Approval in Europe for the Auryon System
From AngioDynamics, Inc.
Via Business Wire
News headline image
PDD Holdings, Daqo New Energy And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
AngioDynamics to Participate in Upcoming Investor Conferences
From AngioDynamics, Inc.
Via Business Wire
News headline image
Nasdaq Edges Lower; Morgan Stanley Earnings Top Views ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >